Faculty Biography

Patrick Brosnan, MD

Back

Education:

B.S., Biology: Saint Peter's College, Jersey City, New Jersey

M.D., Georgetown University School of Medicine, Washington, D.C.

Residency, Pediatrics: Children's Hospital of Philadelphia, Pennsylvania

Chief Resident, Pediatrics: Hospital of the University of Pennsylvania, Philadelphia, PA

Fellowship, Pediatric Endocrinology: University of Texas Medical Branch, Galveston, TX

Clinical and Research Interests:

1. Pediatric Diabetes
2. Resident and Student Education

Publications (selected):

• Abstracts

• Brosnan PG, Toguri, et al:, A New Familial Syndrome of Male Pseudohermaphroditism With Associated Anomalies of Ectoderm and Mesoderm. Pediatric Research 1979; 12(4P+2):484. (Oral Presentation)
• Stuart CA, Brosnan PG, et al: Mechanism of Action of Somatomedin-C in Cartilage. Endocrine Society 1979 (Oral Presentation)
• Brosnan PG, (sponsor Meyer W.). Spontaneous Resolution Under Ultrasonic Observation of Ovarian Cysts Causing Precocious Pseudopuberty Pediatric Research 1985:10(4P+2):182A
• Eric M. Smith, Patrick Brosnan, Walter J. Meyer III, and Edwin Blalock “An ACTH Receptor on Human Mononuclear Leukocytes” NATO Advances Research Workshop, Antalya, Turkey, 1987 (Oral Presentation)
• Brosnan PG (sponsor W. Riley). Growth Hormone Deficiency and Moyamoya. Society for Pediatric Research Seattle 1994 (Ped. Res. 1994: V 35, April 1994) (Poster Presentation)
• Brosnan C, Brosnan PG, Riley W, Therell B, A Cost Study of Newborn Screening for CAH in Texas. 11th National Newborn Screening Symposium, 1st North American Newborn Screening Symposium, Corpus Christi, TX 1995 (Poster Presentation)
• Brosnan CA, Brosnan PG, Therell BL, Kemp S.,Scott C, Blackett P, Jelley D, Domek D, Riley W. CAH in Arkansas and Oklahoma, (PESTOLA) Annual Meeting, Dallas, TX April 1996 (Oral Presentation)
• Brosnan CA, Riley WJ, Brosnan PG, and Therell BL, The Cost Effectiveness of Newborn Screening For Congenital Adrenal Hyperplasia (CAH) due to 21-Hydroxylase Deficiency. International Society. For Neonatal Screening III, Boston, October 1996 (Poster Presentation)
• Brosnan CA, Brosnan PG, Riley WJ,Are CAH Babies Larger, PESTOLA Annual Meeting, San Antonio, TX April 1997 (Oral Presentation)
• Yafi M, Brosnan PG, Hardin DS. Treatment of Type 2Y Diabetes. American Diabetes Association 61st Scientific Session, Philadelphia, May, 2001 (Poster presentation)
• Hardin DS, Yafi M, Gibson AL, Brosnan PG. Clinical Features of Type 2 Diabetes of Youth. American Diabetes Association 61st Scientific Session, Philadelphia, May 2001 (Oral presentation)
• Brosnan CA, Grimes DE, Brosnan PG. Neonatal Screening for Congenital Adrenal Hyperplasia. Pediatric Research: Abstracts Issue, 49(6), 46A, 2001 International Pediatric Endocrinology Montreal 2001. Montreal, Canada: July, 2001. (Poster presentation)
• Brosnan CA, Meininger JC, Swank PR, Reyes LR, Brosnan PG. Ambulatory blood pressure monitoring in adolescents with type 2 diabetes. Pediatric Research: Abstracts Issue, 49(6), 106A, 200.1International Pediatric Endocrinology Montreal 2001. Montreal, Canada: July, 2001.(Poster presentation)
• Valentine LI, Kirkpatrick TJ, Au KS, Rose VM, Brosnan PG, et al: Genotype/Phenotype Correlations in X-Linked Hypophosphatemic Rickets. 52nd Annual Meeting for The American Society of Human Genetics, October 15-19, 2002 Baltimore, Maryland (Poster Presentation)
• Valentine LI, Kirkpatrick TJ, Au KS, Rose VM, Brosnan PG, et al: Genotype/Phenotype Correlations in X-Linked Hypophosphatemic Rickets. The American Journal of Human Genetics, Vol. 71, No.4, P.535, October 2002 (Abstract #2144)
• Brosnan PG, Slover R, Willi S, Silverstein J, Furlanetto R, Fenton C, Ponder S, Lai D, Portman R. Prevalence of Microalbuminuria (MA) in Children and Adolescents with Diabetes Mellitus (DM) and Rate of Spontaneous Remission. 2006 Pediatric Academic Societies’ Annual Meeting, San Francisco, CA, April 28 – May 2, 2006 (Poster Symposium) #750877
• Slover R, Brosnan PG, Willi S, Silverstein J, Furlanetto R, Riley W, Ponder S, Lai D, Portman R. Predictors of Microalbuminuria (MA) in Children with Diabetes Mellitus (DM) 2006 Pediatric Academic Societies’ Annual Meeting, San Francisco, CA, April 28 – May 2, 2006 (Poster Symposium) #753157
• Davis V, Brosnan PG, Silverstein J, Furlanetto R, Riley W, Ponder S, Portman R. Pediatric type 2 diabetes: current evaluation and treatment in the US. 2006 Endocrine Society 88th Annual Meeting. June 24-27, 2006 Boston, MA (Poster #851368)

• Refereed Journal Articles

• Yousefzadeh D, Brosnan PG, et al:Infantile Cortical Hyperostosis. Skeletal Radiology 1979;4:141-47
• Brosnan PG, Toguri A, et al:A New Syndrome of Gonadal Dysgenesis. Pediatr 1980;97:586-590
• Stuart CA, Brosnan PG, Furlanetto The Somatomedin-C Receptor of Human Placenta. Metabolism 1984;33:90-96
• Meyer WM, Brosnan PG, Matustik C:Human Chorionic Gonadotropin Testing. ADJC 1984;138:181-182
• Smith EM, Brosnan PG, Meyer WJ:. An ACTH receptor on human mononuclear leukocytes: relation to adrenal ACTH-receptor activity. NEJM 1987;1317:1266-1269
• Worley KC, Towbin JA, Zuh M, Baker DF, Ballabio A, Chamberlain J, Biesecker LG, Blethem SL, Brosnan P, Fox JE, Rizzo WB, Romeo G, Skuragawa N, Seltzer WK,
• Yamaguchi S, and McCabe ERB: Indication of New Markers in Xp21 between DXS28 (C7) and DMD. GENOMICS 13, 957-961 (1992)
• Brosnan C, Brosnan PG, Riley W, Therell B, A Cost Study of Newborn Screening, Symposium Proceedings of the 11th National Newborn Screening Symposium, Washington 1995
• Brosnan CA, Brosnan PG, Therell B, Slater C, Swint JM, Annegers JF, Riley W. A Comparative Cost Analysis of Newborn Screening for Classic Congenital Adrenal Hyperplasia in Texas. Public Health Reports 113:170-178, 1998
• Vassilopoulou-Sellin R, Brosnan P, Delpassand A, Zietz H, Klein MJ,Osteopenia in Young Adult Survivors of Childhood Cancer. Journal of Medical and Pediatric Oncology 32:272-278, 1999
• Mootha SL, Riley WJ, Brosnan PG, Hypothalamic-Pituitary Dysfunction Associated with Moyamoya Disease in Children. Journal of Pediatric Endocrinology And Metabolism 12:449-453, 1999
• Brosnan PG, Brosnan CA, Kemp SF, Domeck DB, Jelley DH, Blackett PR, Riley WJ. Effect of Newborn Screening for Congenital Adrenal Hyperplasia. Archives of Pediatrics & Adolescent Medicine 153: 1272-1278, 1999
• Brosnan CA, Brosnan PG. Methodologic Issues in Newborn Screening Evaluation with Special Reference to Congenital Adrenal Hyperplasia. J of Pediatric Endocrinology and Metabolism 13(9) 1555-1562, 2000
• Alaswad B, Brosnan PG. The Association of Celiac Disease, Diabetes Mellitus Type 1, Hypothyroidism, Chronic Liver Disease, and Selective IgA Deficiency.Clinical Pediatrics 39: 229-231, 2000
• Brosnan CA, Brosnan PG, Swint JM. Analyzing the cost of neonatal screening for congenital adrenal hyperplasia. [Letter to the editor]. Pediatrics 107(5), 1238-1239, 2001.
• Brod S, Orlander P, Lavis V, Brosnan PG, Hardin DS, Henninger E, Riley W. Ingested IFN- prolongs the “honeymoon” period in newly diagnosed type 1 diabetes mellitus. J Interferon Cyt Res. 21:1021-1030, 2001
• Yafi M, Brosnan PG, Hardin DS. Treatment of type 2 diabetes in children and adolescents. J Ped Endo & Metab Vol.15, Suppl 1, 2002
• Brosnan CA, Meinenger JC, Swank PR, Reyes L, Brosnan PG. Blood pressure profile in adolescents with recently diagnosed type 2 diabetes. Diabetes Care, Vol 25, No. 12, Dec, 2002

 

Location & Contact

6431 Fannin Street
MSB 3.020
Houston, Texas 77030
713-500-5757 (Voice)

Faculty Biography

• Patrick Brosnan, MD
  Professor and Division Head
• Department of Pediatrics
  Division of Endocrinology
• University of Texas-Houston Medical School
  6431 Fannin Street, MSB 3.122
  Houston, Texas 77030
• phone: (713) 500-5646
  fax: (713) 500-0526
  e-mail: Patrick.G.Brosnan@ uth.tmc.edu
• Executive Assistant:
  Aurora Ramirez | (713) 500-5646